MedTrace Logo

Different Local Anesthetic Volumes in Brachial Plexus Block

NCT04549779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2023-06-05

No results posted yet for this study

Summary

This prospective randomized study will be carried out on 75 patients in our university hospitals presented for shoulder arthroscopy under general anesthesia and ultrasound-guided interscalene brachial plexus block.

All the patients will receive ultrasound-guided interscalene brachial plexus block with injection of local anesthetic volume according to the group of the patient

* Group I (25 patients): patients will receive 5 ml levobupivacaine 0.25% ISPB
* Group II (25 patients): patients will receive 10 ml levobupivacaine 0.25% ISPB
* Group III (25 patients): patients will receive 15 ml levobupivacaine 0.25% ISPB After ensuring adequate sensory and motor blockade, general anesthesia will be carried out.

The primary outcome measurement will be the incidence of diaphragmatic hemiparesis 30 minutes after performing the block detected by US assessment of diaphragmatic excursion and the secondary outcome will be the postoperative pain scores and opioid consumption.

Conditions

  • Diaphragmatic Disorder

Interventions

PROCEDURE

Low volume interscalene brachial plexus block

ultrasound-guided interscalene brachial plexus block with 5 ml levobupivacaine 0.25%

PROCEDURE

Intermediate volume interscalene brachial plexus block

ultrasound-guided interscalene brachial plexus block with 10 ml levobupivacaine 0.25%

PROCEDURE

High volume interscalene brachial plexus block

ultrasound-guided interscalene brachial plexus block with 15 ml levobupivacaine 0.25%

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sameh Abdelkhalik · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-19
Primary Completion
2021-08-24
Completion
2022-08-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04549779 on ClinicalTrials.gov